Shigella tetravalent bioconjugate vaccine

Shigella tetravalent bioconjugate vaccine · LimmaTech Biologics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Shigella tetravalent bioconjugate vaccine, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Human Challenge Study to Assess Protection of a Shigella Tetravalent Bioconjugate Vaccine [Phase 2]